Furthermore, 12 months after injecting ALZ17 mice with brain homogenate from mice that had been injected with the human tau P301S transgene 18 months earlier, the ALZ17 mice showed fewer tau inclusions than those of mice that had been injected with AGD brain extracts (40). The gene discussed is MAPT; the disease is argyrophilic grain disease.